
-
Julia Roberts, Jude Law to feature at star-packed Venice Film Festival
-
Stocks slip as investors eye tariff impact among corporate earnings
-
General Motors profits fall on tariffs
-
Extreme weather misinformation 'putting lives at risk,' study warns
-
Russia seeks to fine web users searching for content deemed 'extremist'
-
Paret-Peintre delivers Tour de France home win in Mont Ventoux thriller
-
Janeth Chepngetich books world championships slot with upset win
-
French Open sensation Boisson withdraws injured from Montreal
-
France's culture minister to be tried on corruption charges
-
US Treasury chief says no reason for Fed chair to step down
-
Coca-Cola plans US cane sugar alternative after Trump push
-
US to leave UN cultural body, citing 'national interest'
-
India's Gill accuses England of ignoring 'spirit of the game' by time-wasting
-
Heat forces new Acropolis closure amid fiery temperatures
-
US Treasury chief eyes China tariff deadline extension in talks next week
-
Mbeumo thrilled to follow in Ronaldo's footsteps at 'biggest club in the world' Man Utd
-
Alcaraz withdraws from Toronto event for Wimbledon recovery
-
Markets mixed as investors eye earnings and Trump tariffs
-
India's Gill accuses England of ignoring 'spirit of the game' with time-wasting
-
Van der Poel drops out of Tour de France with pneumonia
-
Stokes ready to push through pain barrier against India
-
Newcastle cult hero 'Nobby' Solano appointed Pakistan coach
-
Heatwave hits water, electricity supplies across much of Iran
-
Pakistan landslide after heavy rain kills 5, with 15 missing
-
AstraZeneca to invest $50 bn in the US as tariff threat looms
-
Lions survive ferocious test to edge First Nations and Pasifika XV
-
Gaza hospital says 21 children dead from malnutrition and starvation
-
France's top diplomat calls for foreign press access to Gaza
-
Top French diplomat visits Ukraine frontline region
-
Bangladesh seethes as toll from jet crash at school hits 31
-
Moscow not expecting 'breakthroughs' from Ukraine talks
-
Former England star Gascoigne released from hospital
-
Stocks diverge with eyes on earnings, trade talks
-
Philippines flooding displaces thousands as new storm threatens
-
Price hikes nibble at demand for Lindt chocolate
-
Amnesty urges probe into Israeli strike on Tehran prison
-
New vines bring hope to Israeli monastery scorched by wildfire
-
China's top football body to form esports team after World Cup flop
-
Kenya athletics trials under shadow of Chepngetich suspension
-
Stocks mixed with trade and earnings in focus
-
Pakistan landslide after heavy rain kills 3, with 15 missing
-
UK gives green light to £38 bn Sizewell C nuclear plant
-
AstraZeneca says to invest $50 bn in the US
-
New-look Australia swim team use worlds to build towards LA 2028
-
Kurdish farmers return to mountains in peace as PKK tensions calm
-
Bangladesh mourns as toll from jet crash at school hits 27
-
'Gloves are off': cancelled Late Show host comes out swinging for Trump
-
India face Bumrah dilemma as England search for top order stability
-
MAGA-style 'anti-globalist' politics arrives in Japan
-
Anxiety and pride among Cambodia's future conscripts

AstraZeneca says to invest $50 bn in the US
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.
A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030.
"Today’s announcement underpins our belief in America’s innovation in biopharmaceuticals," the statement quoted CEO Pascal Soriot as saying.
US President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which have so far benefited from exemptions to his sweeping levies on imports from trading partners.
He ordered an investigation launched into pharmaceutical imports, suggesting that levies could reach up to 200 percent.
The United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States.
"For decades Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a statement.
He added that the new tariffs are focused on "ending this structural weakness".
The announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment".
Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have, in recent months, begun shifting investment and production to the United States.
C.Garcia--AMWN